Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation.
about
Erythropoietin or darbepoetin for patients with cancerEffects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished dataErythropoiesis-stimulating agents in the management of cancer patients with anemia: a meta-analysis.Erythropoietin and cancer: the unintended consequences of anemia correctionMeta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials.Epoetin beta for the treatment of chemotherapy-induced anemia: an update.Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial.Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis.Venous Thromboembolism in Patients Diagnosed With Lung Cancer.Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey.Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients.Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor.Questionnaire-based survey on chemotherapy-induced anemia.
P2860
Q24202335-D8AF6F7B-12A0-4E6F-B6E6-D7D592EFD991Q30803363-6287660A-36DD-4D55-9330-79478D52751AQ33827405-663BEDB5-BAE8-4333-883C-892A9A791827Q34488415-4E2C8E68-B0F3-449D-8C15-7BD69556E5B6Q34554073-888BBC75-96FD-408D-975E-BDD205AABA03Q35168681-C200AF23-7518-4733-AAAF-C24AE7EC8B55Q37355996-072594CB-452E-43E8-AA45-75243E955AACQ38130141-6FDDCCAD-009E-49E3-AA7B-44769B1723DFQ38944457-3CFF1C35-5B54-4D56-8F5A-1F695E7BC20DQ39297030-60B65DA1-C758-46F5-AB13-A9BDF8BE7A22Q45326017-EC1D8D4D-E993-433F-A3C7-E2ADB430CCB8Q47143849-55650C89-273D-4A97-88F3-C59A4305BACDQ50477470-1EB04903-B86E-4551-9203-38F1CF391DE8
P2860
Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Randomised, phase III trial of ...... ccording to the EU regulation.
@ast
Randomised, phase III trial of ...... ccording to the EU regulation.
@en
type
label
Randomised, phase III trial of ...... ccording to the EU regulation.
@ast
Randomised, phase III trial of ...... ccording to the EU regulation.
@en
prefLabel
Randomised, phase III trial of ...... ccording to the EU regulation.
@ast
Randomised, phase III trial of ...... ccording to the EU regulation.
@en
P2093
P2860
P356
P1476
Randomised, phase III trial of ...... ccording to the EU regulation.
@en
P2093
T Sugiyama
Y Fujisaka
P2860
P2888
P304
P356
10.1038/BJC.2011.395
P407
P577
2011-09-29T00:00:00Z
P5875
P6179
1021694710